AVXL: anavex.com PEG multiplikatori
Kutilayotgan EPS o'sishiga nisbatan narx-foyda ko'rsatkichi Alzheimer va Rett sindromini davolash uchun blarcamesinega nisbatan tasdiqlash kutimlari bilan bog'liq bo'lib, joriy daraja 0.00 ni tashkil etadi. Anavex Life Sciences neyrobiologiya sohasidagi yetakchi innovator sifatidagi maqomi orqali ilmiy hamjamiyatning ishonchini saqlab qolmoqda. Shu bilan birga, kompaniya qat'iy global sertifikatsiya standartlariga muvofiq ishlab chiqarish ob'ektlari va laboratoriyalarini modernizatsiya qilmoqda.
Anavex Life Sciences (AVXL) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati Anavex Life Sciences|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati anavex.com|AVXL - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Anavex Corp|AVXL - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Anavex Life Sciences|Kritik likvidlik koeffitsiyenti anavex.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
AVXL - Sof foyda|Kutilayotgan sof foyda Anavex Life Sciences|AVXL - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Anavex Life Sciences Corp|AVXL - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Anavex Corp|AVXL - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Anavex Life Sciences|AVXL - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi anavex.com|AVXL - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Anavex Life Sciences
Kompaniyaning fundamental tahlili:Anavex AVXL
PEG koeffitsiyenti P/E ko'rsatkichini kutilayotgan foyda o'sishi bilan bog'laydi, bu esa aksiya narxining biznes kengayish sur'atlari bilan oqlanish-oklanmasligini aniqlash imkonini beradi. Bozor kapitalizatsiyasi demensiyaga qarshi dori vositalari sinovlari natijalariga bog'liq bo'lgan Anavex Life Sciences (AVXL) uchun PEG nisbiy past baholanganlik metriki, kompaniyaning fundamental qiymati kontekstida bozor uning molekulalarining kelgusidagi muvaffaqiyati uchun haddan tashqari ko'p to'layotgan-to'lamayotganligining ko'rsatkichi bo'lib xizmat qiladi.
Raqobatdosh kompaniyalar
Biogen Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|PEG multiplikatori Regencell Corp RGC|AXSM: Narx-foyda va o‘sish multiplikatori|ACAD: Narxning foydaga va o‘sish sur’atiga nisbati|XENE: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Viking Therapeutics Inc (VKTX)|Narx-foyda va o‘sish multiplikatori SUPN|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CPRX (Catalyst Corp)|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|HRMY (harmonybiosciences.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|Amylyx Pharmaceuticals Inc - Narxning foydaga va o‘sish sur’atiga nisbati|Trevi Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Praxis Corp PRAX|CBLL: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PRTA (Prothena)|ALEC (Alector Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Annexon Biosciences ANNX|Narx-foyda va o‘sish multiplikatori OMER (Omeros Corporation)|NGNE (Neurogene Therapeutics) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati AC Immune ACIU|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati voyagertherapeutics.com (VYGR)|Neumora Therapeutics, Inc. - PEG multiplikatori|Scilex Holding (SCLX) - Narx-foyda va o‘sish multiplikatori|TVGN: PEG multiplikatori|ACOG - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CGTX (Cognition Therapeutics) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda inhibikase.com IKT|Narxning foydaga va o‘sish sur’atiga nisbati Cassava Sciences (SAVA)|assertiotx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori COYA (Coya Therapeutics)|VTGN - Narx-foyda va o‘sish multiplikatori|Ovid Rx - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acumenpharm.com|CervoMed (CRVO) - Narxning foydaga va o‘sish sur’atiga nisbati|ATHE - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CLNN (Clene Inc) - PEG multiplikatori|PEG multiplikatori PepGen Corp|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|Narxning foydaga va o‘sish sur’atiga nisbati RLMD (relmada.com)|Annovis Bio - Narx-foyda va o‘sish multiplikatori|GRCE: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|KLTO: Narxning foydaga va o‘sish sur’atiga nisbati|neurosense-tx.com (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti RVPH|MTVA (MetaVia Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NeurAxis Inc. NRXS|Narx-foyda va o‘sish multiplikatori HSDT (Helius Medical)|PEG multiplikatori passagebio.com (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti NERV|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Addex Therapeutics Ltd.|ALZN: PEG multiplikatori|Cyclerion Therapeutics, Inc. (CYCN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti KTTA (Pasithea)|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|Brainstorm Cell Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Cara Therapeutics Inc - Narxning foydaga va o‘sish sur’atiga nisbati|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|Narx-foyda va o‘sish multiplikatori MRNS|NKGN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|Narxning foydaga va o‘sish sur’atiga nisbati SAGE (sagerx.com)|PEG multiplikatori SNPX (Synaptogenix)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Trevena Inc. (TRVN)|Vigil Neuro - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati WENA|CERE: PEG multiplikatori
